Immunocore Holdings plc
IMCR
$30.45
-$0.28-0.91%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.76% | 5.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.76% | 5.85% | |||
| Cost of Revenue | -359.65% | 1.48% | |||
| Gross Profit | 786.43% | 16.81% | |||
| SG&A Expenses | 7.20% | -7.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.79% | -1.75% | |||
| Operating Income | 100.52% | 51.79% | |||
| Income Before Tax | -5,295.39% | 103.14% | |||
| Income Tax Expenses | 2,865.90% | -20.63% | |||
| Earnings from Continuing Operations | -16,883.05% | 98.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16,883.05% | 98.28% | |||
| EBIT | 100.52% | 51.79% | |||
| EBITDA | 113.67% | 54.79% | |||
| EPS Basic | -16,920.00% | 98.29% | |||
| Normalized Basic EPS | -5,247.37% | 103.15% | |||
| EPS Diluted | -16,920.00% | 98.29% | |||
| Normalized Diluted EPS | -5,247.37% | 103.15% | |||
| Average Basic Shares Outstanding | 0.12% | 0.22% | |||
| Average Diluted Shares Outstanding | 0.12% | 0.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||